Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Kirk Randal J
Relationship:   10% Owner
City:   Radford
State:   VA
   
Insider Summary:
  
   
Companies Owned :   6    
Direct Shares   3,684,697    

Indirect Shares

   67,796,291      
Direct Value   $162,038,028    

Indirect Value

   $374,282,250      
Total Shares   71,480,988      
Total Value   $536,320,277      


Halozyme Therapeutics Inc $162,017,406 Alaunos Therapeutics $20,621 Halozyme Therapeutics Inc $162,017,406 Alaunos Therapeutics $20,621
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    14   
    0    

     Stock price went up :
    6   
    0    
     Stock price went down :
    8   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
   46.5%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Clinical Data Inc CLDA Director, 10% Owner 2011-04-12 0 2011-04-12 0    Premium*  
            Halozyme Therapeutics Inc HALO 10% Owner 2018-08-28 3,562,388 2018-08-28 6,629,464    Premium*  
            Precipio Inc PRPO 10% Owner 2012-02-03 0 2018-08-28 27,151    Premium*  
            Precigen Inc PGEN 0 2024-05-02 51,557,665    Premium*  
            Alaunos Therapeutics TCRT Director, 10% Owner 2015-12-31 122,309 2015-12-31 9,570,094    Premium*  
            Aquabounty Technologies, Inc. AQB 10% Owner 2020-02-13 0 2020-12-17 11,917    Premium*  
* Premium Members only  

Records found :    271         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 9 of 11
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
PGEN Precigen Inc Chief Executive Officer   •       •       •   2018-06-29 4 A $13.94 $999,987 I/I 63,882 14,815,405 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2018-09-28 4 A $14.31 $999,979 I/I 67,518 15,975,578 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2018-07-31 4 A $14.66 $999,982 I/I 65,657 15,950,961 0 -
CLDA Clinical Data Inc Director   –       •       •   2006-09-06 4 B $14.95 $627,900 I/I 42,000 612,263 2.25 -
CLDA Clinical Data Inc Director   –       •       •   2006-08-29 4 B $15.00 $189,315 I/I 12,621 570,263 2.25 -
CLDA Clinical Data Inc Director   –       •       •   2006-08-28 4 B $15.07 $210,829 I/I 13,990 557,642 2.25 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2018-03-30 4 A $15.33 $999,979 I/I 60,551 14,777,995 0 -
CLDA Clinical Data Inc Director   –       •       •   2006-09-13 4 B $15.42 $471,405 I/I 30,571 642,834 2.25 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2014-05-13 4 B $15.63 $500,457 I/I 32,019 829,379 2.64 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2014-05-12 4 B $15.89 $287,069 I/I 18,066 797,360 2.64 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2018-05-31 4 A $16.20 $999,976 I/I 61,444 14,801,058 0 -
CLDA Clinical Data Inc Director   –       •       •   2006-06-13 4 A $16.27 $5,999,996 I/I 368,720 429,912 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2017-10-31 4 A $16.35 $999,991 I/I 56,701 13,494,202 0 -
CLDA Clinical Data Inc Director   –       •       •   2008-06-20 4 B $16.49 $98,693 I/I 5,985 3,380,985 2.25 -
CLDA Clinical Data Inc Director   –       •       •   2008-09-26 4 A $16.50 $18,000,003 I/I 1,090,744 24,240 0 -
CLDA Clinical Data Inc Director   –       •       •   2008-09-26 4 A $16.50 $6,999,997 D/D 424,178 2,063,458 0 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2018-07-27 4 S $16.90 $826,866 I/I (48,927) 3,616,655 0 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2018-06-29 4 S $16.97 $2,077,654 I/I (122,431) 3,796,606 0 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2018-06-28 4 S $16.99 $2,181,261 I/I (128,385) 3,869,359 0 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2018-08-10 4 S $17.08 $3,466,540 I/I (202,959) 3,276,273 0 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2018-08-15 4 S $17.15 $1,569,928 I/I (91,541) 3,041,722 0 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2018-08-21 4 S $17.15 $2,765,369 I/I (161,246) 2,894,871 0 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2018-08-16 4 S $17.24 $1,644,058 I/I (95,363) 2,985,054 0 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2018-07-26 4 S $17.30 $2,595,000 I/I (150,000) 3,645,729 0 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2018-07-25 4 S $17.32 $1,799,548 I/I (103,900) 3,734,865 0 -
  271  Records found
  1   2   3   4   5   6   7   8   9  10   11      
  Page 9 of 11  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us